1-3 of 3
Michela Salvio
Close
Sort by
Journal Articles

Prognostic Impact of p190 and p210 Co-Expression at Diagnosis in Chronic Myeloid Leukemia (CML) Patients Treated with Imatinib

Gioacchino Catania, Federico Monaco, Massimo Pini, MD, Maria Teresa Corsetti, Michela Salvio, Nicol Trincheri, Francesco Zallio, Daniela Pietrasanta, Anna Baraldi, Depaoli Lorella, Salvi Flavia, MD, Marco Ladetto, MD
Journal: Blood
Blood (2014) 124 (21): 5528.
https://doi.org/10.1182/blood.V124.21.5528.5528
Published: 2014
Journal Articles

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Nicoletta Testoni, PhD, Alfonso Zaccaria, MD, Franca Radaelli, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Federica Sora’, MD, Monica Crugnola, MD, Michele Cedrone, MD, Gianantonio Rosti, MD, Sergio Amadori, MD, Paolo de Fabritiis, MD, Michele Baccarani, MD
Journal: Blood
Blood (2006) 108 (11): 2116.
https://doi.org/10.1182/blood.V108.11.2116.2116
Published: 2006
Journal Articles

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Alfonso Zaccaria, MD, Nicoletta Testoni, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Tommaso Caravita, MD, Paola Panetta, BS, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Franca Radaelli, MD, Federica Sora’, MD, Gianantonio Rosti, Sergio Amadori, MD, Michele Baccarani, MD
Journal: Blood
Blood (2004) 104 (11): 2936.
https://doi.org/10.1182/blood.V104.11.2936.2936
Published: 2004